We are live on ! Find out more
O

OppenheimerFunds Portfolio holdings

AUM $80.4B
1-Year Est. Return 15.1%
This Fund
S&P 500
This Quarter Est. Return
+10.23%
1 Year Est. Return
+15.1%
3 Year Est. Return
+72.05%
5 Year Est. Return
+91.1%
10 Year Est. Return
AUM
$75.5B
AUM Growth
+$6.03B
Cap. Flow
+$664M
Cap. Flow %
0.88%
Top 10 Hldgs %
13.76%
Holding
1,022
New
110
Increased
407
Reduced
342
Closed
107

Top Sells

Rank Stock Value
1
AGN
Allergan plc
AGN
+$440M
2
QCOM icon
Qualcomm
QCOM
+$412M
3
BIDU icon
Baidu
BIDU
+$207M
4
UPS icon
United Parcel Service
UPS
+$185M
5
KO icon
Coca-Cola
KO
+$168M

Sector Composition

Rank Sector Weight
1 Energy 16.71%
2 Financials 13.65%
3 Communication Services 11.71%
4 Technology 11.31%
5 Healthcare 10.43%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
KO icon
451
Coca-Cola
KO
$354B
$28M 0.04%
740,000
-4,240,876
-85% -$168M
SFLY
452
DELISTED
Shutterfly, Inc.
SFLY
$27.9M 0.04%
500,000
BCE icon
453
BCE
BCE
$19.9B
$27.8M 0.04%
650,000
-211,792
-25% -$8.81M
EVHC
454
DELISTED
Envision Healthcare Holdings Inc
EVHC
$27.6M 0.04%
+354,050
New +$28.2M
SLF icon
455
Sun Life Financial
SLF
$45.6B
$27.6M 0.04%
862,515
-87,705
-9% -$2.79M
HCA icon
456
HCA Healthcare
HCA
$84.8B
$27.6M 0.04%
644,811
-10,499
-2% -$410K
SNDK
457
DELISTED
SANDISK CORP
SNDK
$27.5M 0.04%
461,828
-9,098
-2% -$534K
GSK icon
458
GSK
GSK
$103B
$27.4M 0.04%
436,380
+380
+0.1% +$24.5K
CMA
459
DELISTED
Comerica
CMA
$27.3M 0.04%
695,030
-100
-0% -$4.15K
EXPE icon
460
Expedia Group
EXPE
$31.2B
$27.3M 0.04%
526,380
+208,790
+66% +$11.2M
MWIV
461
DELISTED
MWI VETERINARY SUPPLY, INC.
MWIV
$27M 0.04%
180,709
+42,924
+31% +$6.08M
CVC
462
DELISTED
CABLEVISION SYS CP NY GRP CL-A
CVC
$27M 0.04%
1,600,545
-119,730
-7% -$2.19M
AEM icon
463
Agnico Eagle Mines
AEM
$72.6B
$26.7M 0.04%
1,010,000
-690,000
-41% -$19.7M
MAGN
464
Magnera Corp
MAGN
$488M
$26.7M 0.04%
75,935
-332
-0.4% -$115K
EQR icon
465
Equity Residential
EQR
$25.4B
$26.7M 0.04%
498,748
-2,920
-0.6% -$161K
RGA icon
466
Reinsurance Group of America
RGA
$15.7B
$26.5M 0.04%
395,030
+16,960
+4% +$1.14M
PII icon
467
Polaris
PII
$4.15B
$26.1M 0.03%
201,710
+44,250
+28% +$4.97M
SI
468
DELISTED
SIEMENS AKTIENGESELLSCHAFT ADS
SI
$26M 0.03%
215,401
-20,477
-9% -$2.28M
REG icon
469
Regency Centers
REG
$15B
$25.6M 0.03%
529,540
+167,880
+46% +$8.47M
PRAA icon
470
PRA Group
PRAA
$648M
$25.5M 0.03%
424,830
+78,690
+23% +$4.22M
KFY icon
471
Korn Ferry
KFY
$3.98B
$25.3M 0.03%
1,182,359
-1,392
-0.1% -$27.5K
PRLB icon
472
Protolabs
PRLB
$1.86B
$25.3M 0.03%
331,189
+79,310
+31% +$5.49M
PSX icon
473
Phillips 66
PSX
$82.9B
$25.3M 0.03%
436,817
-709,841
-62% -$41.2M
NSH
474
DELISTED
NuStar GP Holdings LLC
NSH
$25.2M 0.03%
1,122,836
-106,977
-9% -$2.58M
QLIK
475
DELISTED
QLIK TECHNOLOGIES INC COM STK (DE)
QLIK
$25.2M 0.03%
735,650
+42,130
+6% +$1.38M

Similar funds

OppenheimerFunds's Q3 2013 Portfolio in Review

As of Q3 2013, OppenheimerFunds held 1,022 positions worth $75.5B, up 8.7% from $69.5B the previous quarter. Its ten largest holdings account for 14% of the portfolio.

OppenheimerFunds's Q3 2013 filing shows 110 new, 407 increased, 342 reduced and 107 closed positions. Its largest new stake was Twenty-First Century Fox, Inc. Class B: 4,300,720 shares worth $144M. The largest sale was Allergan plc, an estimated $440M.

By sector, the portfolio is most concentrated in Energy at 17% of assets, up from 16% a quarter earlier, followed by Financials and Communication Services.

  • OppenheimerFunds's largest Q3 2013 buy was Twenty-First Century Fox, Inc. Class B: 4,300,720 shares worth $144M.
  • OppenheimerFunds added most to Televisa in Q3 2013, an estimated $308M increase.
  • OppenheimerFunds's biggest Q3 2013 reduction was Allergan plc, cutting an estimated $440M.
  • OppenheimerFunds fully exited BROADCOM CORP CL-A in Q3 2013, selling an estimated $164M.
  • OppenheimerFunds's ten largest holdings make up 14% of its $75.5B portfolio in Q3 2013.
  • OppenheimerFunds opened 110 new positions and closed 107 in Q3 2013.
  • OppenheimerFunds's portfolio value rose 8.7% quarter-over-quarter to $75.5B.

Based on OppenheimerFunds's 13F filing for Q3 2013, filed 14 Nov 2013.